Effectiveness of Natalizumab in Extended Dosing Interval

被引：0
|
作者：
Hervas, Jose Vicente [1 ]
Punet-Ortiz, Joan [1 ]
Teniente-Serra, Aina [1 ]
Mansilla, M. Jos [1 ]
Quirant-Sanchez, Bibiana [1 ]
Navarro, Juan [1 ]
Presas, Silvia [1 ]
Martinez-Caceres, Eva [1 ]
Ramo, Cristina [1 ]
机构：
[1] Germans Trias & Pujol Hosp, Badalona, Spain
来源：
NEUROLOGY | 2016年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P3.078
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Effectiveness of natalizumab in extended dosing interval
    Ramo-Tello, C.
    Grau-Lopez, L.
    Vilaro, L.
    Segui, C.
    Delicado, S.
    Bonafont, X.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 213 - 214
  • [2] Effectiveness of natalizumab extended interval dosing in multiple sclerosis patients
    Petrzalka, M.
    Meluzinova, E.
    Mojzisova, H.
    Libertinova, J.
    Rockova, P.
    Nema, E.
    Elisak, M.
    Marusic, P.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2020, 83 (01) : 79 - 83
  • [3] Effectiveness and safety profile of the natalizumab extended interval dosing in a spanish cohort
    Costa-Frossard, L.
    Sainz De La Maza, S.
    Monreal, E.
    Gomez Lopez, A.
    Fernandez-Velasco, J. I.
    Walo Delgado, P.
    Espino, M.
    Villarrubia, N.
    Masjuan, J.
    Villar, L. M.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 278 - 278
  • [4] Real world effectiveness of Natalizumab extended interval dosing in a French cohort
    Pelle, J.
    Briant, A.
    Lebrun-Frenay, C.
    Cohen, M.
    Mondot, L.
    De Seze, J.
    Bigaut, K.
    Collongues, N.
    Kremer, L.
    Ricard, D.
    Bompaire, F.
    Sallansonnet-Froment, M.
    Ohlmann, C.
    Ciron, J.
    Biotti, D.
    Pignolet, B.
    Parienti, J.
    Defer, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 207 - 207
  • [5] Long-term effectiveness of extended interval dosing of natalizumab in multiple sclerosis
    Ryerson, L. Zhovtis
    Lee, S.
    Bacon, T.
    Toth, E.
    Chinea, R.
    Gragui, D.
    Kister, I.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 358 - 359
  • [6] Real-World Effectiveness of Natalizumab Extended Interval Dosing in a French Cohort
    Juliette Pelle
    Anais R. Briant
    Pierre Branger
    Nathalie Derache
    Charlotte Arnaud
    Christine Lebrun-Frenay
    Mikael Cohen
    Lydiane Mondot
    Jerome De Seze
    Kevin Bigaut
    Nicolas Collongues
    Laurent Kremer
    Damien Ricard
    Flavie Bompaire
    Charlotte Ohlmann
    Magali Sallansonnet-Froment
    Jonathan Ciron
    Damien Biotti
    Beatrice Pignolet
    Jean-Jacques Parienti
    Gilles Defer
    Neurology and Therapy, 2023, 12 : 529 - 542
  • [7] Extended-interval dosing of natalizumab in NOVA
    Stuve, Olaf
    Tugemann, Bastian
    LANCET NEUROLOGY, 2023, 22 (03): : 199 - 200
  • [8] Real-World Effectiveness of Natalizumab Extended Interval Dosing in a French Cohort
    Pelle, Juliette
    Briant, Anais R.
    Branger, Pierre
    Derache, Nathalie
    Arnaud, Charlotte
    Lebrun-Frenay, Christine
    Cohen, Mikael
    Mondot, Lydiane
    De Seze, Jerome
    Bigaut, Kevin
    Collongues, Nicolas
    Kremer, Laurent
    Ricard, Damien
    Bompaire, Flavie
    Ohlmann, Charlotte
    Sallansonnet-Froment, Magali
    Ciron, Jonathan
    Biotti, Damien
    Pignolet, Beatrice
    Parienti, Jean-Jacques
    Defer, Gilles
    NEUROLOGY AND THERAPY, 2023, 12 (02) : 529 - 542
  • [9] Efficacy and safety of natalizumab extended interval dosing
    Zeineddine, M.
    Ayyoubi, N.
    Tamim, H.
    Nicolas, J.
    Khoury, S.
    Yamout, B.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 871 - 871
  • [10] Pharmacodynamics of natalizumab extended interval dosing in MS
    Zhovtis Ryerson, Lana
    Li, Xiaochun
    Goldberg, Judith D.
    Hoyt, Tamara
    Christensen, Angel
    Metzger, Ryan R.
    Kister, Ilya
    Foley, John
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2020, 7 (02):
12345